药物设计与发现 1119条(本栏目收费,不能显示细节,电话13136136841)
11C-labeling, 126–127 127
18F-labeling, 127–128 128
physical principle, 121–122 122
radionuclides selection 0
binding vs. functional assays, 206–207 207
constitutively active receptors and inverse 0
negative allosteric modulators, 208, 210–211 211
partial and full agonists, 206–207 207
positive allosteric modulators, 210 210
recombinant vs. insitu assays, 204, 206 206
Cys-loop receptor family, 199–200 200
ionotropic glutamate receptor family, 201–202 202
nuclear receptors, 203–204 204
purinergic P2X receptor family, 202–203 203
tyrosine kinase receptors, 202–205 205
synaptic processes and mechanisms, 195–196 196
Re-entry arrhythmia, 220 220
RNAi, see RNA interference 0
RNA interference (RNAi), 96–98 98
RNAP, see RNA polymerase 0
RNA polymerase (RNAP), 418–419 419